People · Operator

Sri S. Pangulur

Named in public records as an officer, director or promoter · active 2022–2022 · Other Technology

2
Companies
2
Filings
$82.5M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
QuotaPath Inc.Other TechnologySeries B$56.5M$555.0M2022
Orum Inc.Other TechnologySeries B$26.0M$313.3M2022
Operator network

Sri S. Pangulur at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Anthony J. Bruno · 1 companies · 1 sharedAnthony J. BrunoChris Cole Shonk · 1 companies · 1 sharedChris Cole ShonkChristopher Cole Shonk · 1 companies · 1 sharedChristopher Cole …John S. Reale, Jr. · 1 companies · 1 sharedJohn S. Reale, Jr.Matthew Cole Evetts · 1 companies · 1 sharedMatthew Cole Evet…Rachel S. Geller · 1 companies · 1 sharedRachel S. GellerJason Dorfman · 2 companies · 1 sharedJason DorfmanAyush Sood · 1 companies · 1 sharedAyush SoodDavid S. Sacks · 1 companies · 1 sharedDavid S. SacksJason S. Dorfman · 1 companies · 1 sharedJason S. DorfmanKarthik S. Viswanathan · 1 companies · 1 sharedKarthik S. Viswan…Karthik Viswanathan · 1 companies · 1 sharedKarthik Viswanath…QuotaPath Inc. · $56.5M raisedQuotaPath Inc.Orum Inc. · $26.0M raisedOrum Inc.Sri S. PangulurSP
Sri S. Pangulur Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Sri S. Pangulur on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Jason Dorfman12
Jason S. Dorfman11
David S. Sacks11
Karthik S. Viswanathan11
Ayush Sood11
Karthik Viswanathan11
Rachel S. Geller11
Anthony J. Bruno11
John S. Reale, Jr.11
Matthew Cole Evetts11
Chris Cole Shonk11
Christopher Cole Shonk11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.